Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 20, 20 December 2023
Open
Access | Article
Application of different treatment methods for autism
* Author to whom correspondence should be addressed.
Abstract
Today, more than 70 million people around the world suffer from autism, and scientists around the world are working hard to invest in research into autism treatment, hoping to identify the possibility of a cure among the various attempts. At present, there are a large number of studies on various treatment options for autism, but not many summaries of the studies. Due to the complex causes of autism, this research only summarizes some of the therapeutic and training programs that have made progress in autism. This research of existing research suggests that the adverse symptoms of autism can be improved through applied behavior analysis (ABA) therapy, symptom-relieving medications, talk-based cognitive-behavior therapy (CBT), behavioral therapy, gene therapy, gut probiotics supplementation, and web-based training. Although autism is a very complex disease, with the development of technology and in-depth research into its causes, autism is controllable and mitigated. In the future, with more in-depth research, there may be more ways to alleviate the suffering of people with autism.
Keywords
autism, ABA therapy, medications, behavioral therapy, gene therapy
References
1. Velarde, M. and Cárdenas, A., "Trastornos del espectro autista y trastornos por déficit de atención con hiperactividad: desafíos en el diagnóstico y tratamiento [Autism spectrum disorder and attention-deficit/hyperactivity disorder: challenge in diagnosis and treatment]," Medicina 82, 67–70 (2022).
2. Amadi, C. N., Orish, C. N., Frazzoli, C. and Orisakwe, O. E., "Dietary interventions for autism spectrum disorder: An updated systematic review of human studies," Psychiatriki 33, 228–242 (2022).
3. Hirota, T. and King, B. H., "Autism Spectrum Disorder: A Review," JAMA 329, 157–168 (2023).
4. Doyle, C. A. and McDougle, C. J., "Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan," Dialogues in clinical neuroscience 14, 263–279 (2012).
5. Knorz, A. L. and Quante, A., "Alzheimer's Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review," Journal of geriatric psychiatry and neurology 35, 475–486 (2022).
6. D. Tsiopela, A. Jimoyiannis, In: Mikropoulos, T. (eds) Research on e-Learning and ICT in Education. Springer, Cham, 381-395 (2018).
7. Adams, J. B., Audhya, T., Geis, E., Gehn, E., Fimbres, V., Pollard, E. L., Mitchell, J., Ingram, J., Hellmers, R., Laake, D., Matthews, J. S., Li, K., Naviaux, J. C., Naviaux, R. K., Adams, R. L., Coleman, D. M. and Quig, D. W., "Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial," Nutrients 10, 369 (2018).
8. Thompson, C., McDonald, J., Kidd, T., Falkmer, T., Bölte, S. and Girdler, S., "I don't want to be a patient": Peer mentoring partnership fosters communication for autistic university students," Scandinavian Journal of Occupational Therapy 27, 625–640 (2020).
9. Fung, T. C., Olson, C. A. and Hsiao, E. Y., "Interactions between the microbiota, immune and nervous systems in health and disease," Nature neuroscience 20, 145–155 (2017).
10. Pedrazzi, J. F. C., Ferreira, F. R., Silva-Amaral, D., Lima, D. A., Hallak, J. E. C., Zuardi, A. W., Del-Bel, E. A., Guimarães, F. S., Costa, K. C. M., Campos, A. C., Crippa, A. C. S. and Crippa, J. A. S., "Cannabidiol for the treatment of autism spectrum disorder: hope or hype?," Psychopharmacology 239, 2713–2734 (2022).
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
- ISBN (Print)
- 978-1-83558-213-8
- ISBN (Online)
- 978-1-83558-214-5
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/20/20230705
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited